

#323 - CRISPR and the future of gene editing: scientific advances, genetic therapies, disease treatment potential, and ethical considerations | Feng Zhang, Ph.D.
235 snips Oct 28, 2024
Feng Zhang, a groundbreaking professor of neuroscience at MIT and a leader in gene editing, discusses his pioneering work with CRISPR technology. He explores the revolutionary journey of CRISPR, from its discovery to its potential in treating genetic diseases like sickle cell anemia. Zhang also addresses the ethical debates surrounding gene editing, particularly concerning germline modifications. He shares insights from his personal journey, the impact of mentorship, and the future potential of genetic medicine, highlighting both challenges and innovative solutions in the field.
AI Snips
Chapters
Transcript
Episode notes
Optogenetics Development
- Feng Zhang helped develop optogenetics, a technique enabling precise brain cell control using light.
- He used viruses to insert algal genes into mouse brain cells, controlling their activity with light.
Precise Gene Targeting
- Precise gene targeting within the genome was crucial for refining optogenetics.
- Different brain cell types have unique molecular signatures, requiring targeted gene insertion for specific cell control.
CRISPR Discovery
- In the 1980s, researchers discovered clustered, repetitive DNA sequences in bacteria, initially named CRISPR.
- These "clustered regularly interspaced short palindromic repeats" were later found to have a crucial function.